Marc Bonten

CEO, European Clinical Research Alliance on Infectious Diseases (ECRAID)

Marc Bonten (born 16-10-1964) got his MD (1991) and PhD (“the role of colonization of the upper intestinal tract in the pathogenesis of ventilator-associated pneumonia, 1994) at the Maastricht University Medical School, the Netherlands. He registered as internist in 2000, as infectious disease specialist in 2002 and as clinical microbiologist in 2008, all at the University Medical Center Utrecht, the Netherlands. From 2008 till April 2021 he was head of the department Medical Microbiology. Since 2003 he is professor of molecular epidemiology of infectious diseases and leading the research group of infectious Disease Epidemiology of the Julius Center of Health Sciences and Primary Care at UMC Utrecht.
He serves as the chair the Infection & Immunity Focus Programme of the UMC Utrecht. He is a VICI laureate from the Dutch Science Association (2006), received the Excellence Award of the European Society of Clinical Microbiology and Infectious Diseases (2015) and is Member of the Royal National Academy of Sciences (since 2021). He is coordinator of the HORIZON2020 projects ECRAID-Base and ECRAID-Prime, scientific coordinator of the IMI-funded consortiums COMBACTE-NET, COMBACTE-CARE and COMBACTE-MAGNET, and since January 2022 CEO of Ecraid (European Research Alliance on Infectious Diseases). He is member of the International Trial Steering Committees of the REMAP-CAP and SNAP study.